M. Shankar, N.L. Gowrishankar, S. Narendiran, K. Sudhakar
M. Shankar*, N.L. Gowrishankar, S. Narendiran and K. Sudhakar
Department of Pharmaceutical Chemistry, Swami Vivekanandha Institute of Pharmaceutical Sciences, Vangapally (V), Yadhagirigutta (M), Nalgonda (District), Pin - 508286, Andhra Pradesh.
Volume - 5,
Issue - 1,
Year - 2012
The protein-ligand interaction plays a significant role in the structural based drug designing. In our research work we have taken the cyclo-oxygenase receptor (COX). The receptor was docked to the commercially available NSAID (Non Steroid Anti Inflammatory Drugs) Celecoxib and Naproxen Protein Structure Modeling Method, using INSIGHTII software. We tried to improve the binding efficiency and steric compatibility of Celecoxib and Naproxen against COX receptor. Several modifications were made to the probable functional groups which were interacting with receptor molecule. Analogs of the drug molecule were prepared using MODELLER9v1chemsketch and docked using INSIGHT II docking software. The modified drugs was sketched using chemsketch were found to be better than the convectional drugs available. Further from this work we can improve the steric compatibility and then Absorption, Distribution, Metabolism and Excretion (ADME) properties of the analogs can be analyzed using Insilco ADME tools.
Cite this article:
M. Shankar, N.L. Gowrishankar, S. Narendiran, K. Sudhakar. Denovo Design of the Lead against Cyclo-Oxygenase Receptor. Asian J. Research Chem. 5(1): January 2012; Page 38-43.
M. Shankar, N.L. Gowrishankar, S. Narendiran, K. Sudhakar. Denovo Design of the Lead against Cyclo-Oxygenase Receptor. Asian J. Research Chem. 5(1): January 2012; Page 38-43. Available on: https://www.ajrconline.org/AbstractView.aspx?PID=2012-5-1-7